Virtu Financial’s Revelation Biosciences, Inc. Unit REVBU Stock Holding History

Virtu Financial’s Portfolio REVBU Stock Details REVBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,023	Closed	-$4K	–	2463
2022 Q3	$4K	Buy	+11,023	New	+$7.61K	﹤0.01%	1597

Other funds holding REVBU

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's REVBU Position: Q4 2022 in Review

Virtu Financial sold out of Revelation Biosciences, Inc. Unit (REVBU) in Q4 2022, closing a stake of 11,023 shares — an estimated $4K sold.

Virtu Financial first reported a position in REVBU in Q3 2022 and held it in 1 quarter. The position peaked at $4K in Q3 2022. 4 funds tracked by Wall St. Rank hold REVBU as of Q4 2022.

Virtu Financial reported no remaining Revelation Biosciences, Inc. Unit position as of Q4 2022 after selling out during the quarter.
Virtu Financial sold 11,023 Revelation Biosciences, Inc. Unit shares in Q4 2022, an estimated $4K.
Virtu Financial first reported a position in Revelation Biosciences, Inc. Unit in Q3 2022 and held it in 1 quarter.
Virtu Financial's Revelation Biosciences, Inc. Unit position peaked at $4K in Q3 2022.
4 funds tracked by Wall St. Rank held Revelation Biosciences, Inc. Unit as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.